Home
Issues
Deals
Ledger
Research
About
Lilly buys AtaiBeckley
·
$3.8bn
Otsuka buys Transcend
·
$1.2bn
AbbVie buys Gilgamesh
·
$1.2bn
atai buys Beckley Psytech
·
terms undisclosed
AbbVie takes an option on Gilgamesh
·
$2bn
Lilly buys AtaiBeckley
·
$3.8bn
Otsuka buys Transcend
·
$1.2bn
AbbVie buys Gilgamesh
·
$1.2bn
atai buys Beckley Psytech
·
terms undisclosed
AbbVie takes an option on Gilgamesh
·
$2bn
Lilly buys AtaiBeckley
·
$3.8bn
Otsuka buys Transcend
·
$1.2bn
AbbVie buys Gilgamesh
·
$1.2bn
atai buys Beckley Psytech
·
terms undisclosed
AbbVie takes an option on Gilgamesh
·
$2bn
Next issue
Issue 16 · Tue 29 Sep
All issues
ARQ Centrum'45
Every issue covering ARQ Centrum'45.
1 issue
2026-09-08
No. 13
Three authorised, one counted.
TRIALS
REGULATORY
SLAGELSE
CHIETI
AMSTERDAM-UMC
ARQ
DEFINIUM